Fosamax 70mg extended indications for man's osteoporosis

MSD Korea has extended the indication of Fosamax 70mg under the KFDA approval from the current osteoporosis treatment for the post menopause women by administering once a week, to osteoporosis for the men in the future, which will be NHI reimbursable at a similar standard with other osteoporosis drugs.

The above approval will be the first occasion in Korea as far as the anti-osteoporosis dru...